A new treatment is effective for advanced HER2-low breast cancer
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease an...
Treatment with trastuzumab deruxtecan, a combination of a targeted therapy with chemotherapy, increases progression-free survival of the disease an...
The Hospital Clínic de Barcelona is consolidating its transorbital surgery programme for patients with skull base tumours. This surgery is led by t...
IDIBAPS publishes more than 300 scientific articles on the disease every year, which represent 22.5% of the total number of publications of the ins...
We speak to Dr. Mertixell Mollà, head of the Radiation Oncology Service and coordinator of the Hospital Clínic Cancer Technical Committee, about th...
A study conducted at Hospital Clínic analysed the genetic profile of more than 300 patients with solid tumours using a liquid biopsy blood test, re...
• The International Agency for Research on Cancer (IARC) has compiled a review of all the literature written on existing screening and follow-up te...
Interview with Dr Maria Reig, head of the Hepatic Oncology Unit
The Hospital Clínic-IDIBAPS researcher has been awarded in the basic research category.
On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organizati...
The Hospital Clínic Medical Oncology Service, led by Dr. Aleix Prat, has launched a home infusion programme for solid organ cancer patients and imm...